Cargando…

New Treatment Paradigms Defined for Chronic Lymphocytic Leukemia

Within the past 3 years, the FDA has approved five new treatment options for patients with CLL. While these advances improve patient outcomes and the quality of care, there is a need for advanced practitioners to stay up to date and informed in order to translate these advances into the clinical set...

Descripción completa

Detalles Bibliográficos
Autores principales: Moran, Mollie, Jones, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003763/
https://www.ncbi.nlm.nih.gov/pubmed/29928551